Precision Oncology in the Space Between Data and Delivery: Dr. Benedikt Westphalen’s Vision for the...
A tumor can be sequenced in extraordinary detail and still leave the patient with no meaningful option. That...
30
Apr
20
Apr
Rethinking the myth of the “Dark Side” With Dr. Lokesh Jain
The transition from clinical practice or a research career to the pharmaceutical industry is often met with the...
14
Apr
What It Takes to Lead at the Top: Dr. Roy Baynes and the Discipline of...
There is one idea that seems to sit at the center of Dr. Roy Baynes’s career, and perhaps...
06
Apr
Precision Medicine Through the Patient Lens: The Wondrlink Impact
Precision medicine is reshaping oncology by shifting treatment selection from histology alone to the molecular architecture of each...
02
Apr
Oncology Trial Recruitment in the Age of AI: Strategic Insights for Clinical Development Leaders
Over the past decade, oncology drug development has undergone a profound scientific transformation. Biomarker-driven therapies, adaptive designs, and...
26
Mar
AI-Generated Control Arms in Clinical Trials: Evidence, Opportunities, and Strategic Considerations
Clinical trials are undergoing structural change. As therapies become more targeted and patient populations more fragmented, the traditional...
